Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Cerenome cash
Cash and short-term investments held at the end of each period.
Cerenome's cash was $8.59M at Jun 30, 2026. For fiscal 2025 it was $13.10M, up 263.3% from the year before. Over ten years it grew -7.5% a year on average. The highest annual figure on record is $67.57M in fiscal 2011.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.10M | +263.3% |
| FY2024 | Dec 31, 2024 | $3.61M | -57.8% |
| FY2023 | Dec 31, 2023 | $8.55M | -52.8% |
| FY2022 | Dec 31, 2022 | $18.12M | -1.5% |
| FY2021 | Dec 31, 2021 | $18.40M | +120.5% |
| FY2020 | Dec 31, 2020 | $8.35M | -52.4% |
| FY2019 | Dec 31, 2019 | $17.55M | +233.6% |
| FY2018 | Dec 31, 2018 | $5.26M | -44.9% |
| FY2017 | Dec 31, 2017 | $9.55M | -24.2% |
| FY2016 | Dec 31, 2016 | $12.60M | -56.1% |
| FY2015 | Dec 31, 2015 | $28.68M | +26.0% |
| FY2014 | Dec 31, 2014 | $22.77M | +13.0% |
| FY2013 | Dec 31, 2013 | $20.15M | -36.8% |
| FY2012 | Dec 31, 2012 | $31.86M | -52.8% |
| FY2011 | Dec 31, 2011 | $67.57M | +28.3% |
| FY2010 | Dec 31, 2010 | $52.67M | +309.7% |
| FY2009 | Dec 31, 2009 | $12.85M | +1.9% |
| FY2008 | Dec 31, 2008 | $12.61M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.59M | +24.8% |
| Q1 FY2026 | Mar 31, 2026 | $15.11M | +53.2% |
| Q4 FY2025 | Dec 31, 2025 | $13.10M | +263.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.60M | +246.7% |
| Q2 FY2025 | Jun 30, 2025 | $6.88M | -18.4% |
| Q1 FY2025 | Mar 31, 2025 | $9.87M | +206.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.61M | -57.8% |
| Q3 FY2024 | Sep 30, 2024 | $4.79M | -56.5% |
| Q2 FY2024 | Jun 30, 2024 | $8.44M | -22.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.22M | -74.7% |
| Q4 FY2023 | Dec 31, 2023 | $8.55M | -52.8% |
| Q3 FY2023 | Sep 30, 2023 | $11.01M | -45.7% |
| Q2 FY2023 | Jun 30, 2023 | $10.90M | -39.8% |
| Q1 FY2023 | Mar 31, 2023 | $12.72M | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $18.12M | -1.5% |
| Q3 FY2022 | Sep 30, 2022 | $20.27M | -4.8% |
| Q2 FY2022 | Jun 30, 2022 | $18.09M | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | $21.24M | +47.0% |
| Q4 FY2021 | Dec 31, 2021 | $18.40M | +120.5% |
| Q3 FY2021 | Sep 30, 2021 | $21.28M | +179.0% |
| Q2 FY2021 | Jun 30, 2021 | $17.16M | +85.2% |
| Q1 FY2021 | Mar 31, 2021 | $14.45M | -10.0% |
| Q4 FY2020 | Dec 31, 2020 | $8.35M | -52.4% |
| Q3 FY2020 | Sep 30, 2020 | $7.63M | -54.7% |
| Q2 FY2020 | Jun 30, 2020 | $9.27M | +104.5% |
| Q1 FY2020 | Mar 31, 2020 | $16.06M | +314.8% |
| Q4 FY2019 | Dec 31, 2019 | $17.55M | +233.6% |
| Q3 FY2019 | Sep 30, 2019 | $16.83M | +147.3% |
| Q2 FY2019 | Jun 30, 2019 | $4.53M | -23.2% |
| Q1 FY2019 | Mar 31, 2019 | $3.87M | -59.5% |
| Q4 FY2018 | Dec 31, 2018 | $5.26M | +10.0% |
| Q3 FY2018 | Sep 30, 2018 | $6.81M | -24.6% |
| Q1 FY2018 | Mar 31, 2018 | $5.90M | -10.6% |
| Q4 FY2017 | Dec 31, 2017 | $9.55M | -24.2% |
| Q3 FY2017 | Sep 30, 2017 | $4.78M | -68.0% |
| Q2 FY2017 | Jun 30, 2017 | $9.03M | -55.0% |
| Q1 FY2017 | Mar 31, 2017 | $6.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.60M | – |
| Q3 FY2016 | Sep 30, 2016 | $14.92M | – |
| Q2 FY2016 | Jun 30, 2016 | $20.04M | – |
See a number that looks wrong?